Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Evaluating biological activity of compounds by transcription factor activity profiling.

Medvedev A, Moeser M, Medvedeva L, Martsen E, Granick A, Raines L, Zeng M, Makarov S Jr, Houck KA, Makarov SS.

Sci Adv. 2018 Sep 26;4(9):eaar4666. doi: 10.1126/sciadv.aar4666. eCollection 2018 Sep.

2.

Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system.

Wetmore BA, Clewell RA, Cholewa B, Parks B, Pendse SN, Black MB, Mansouri K, Haider S, Berg EL, Judson RS, Houck KA, Martin M, Clewell HJ 3rd, Andersen ME, Thomas RS, McMullen PD.

Toxicol In Vitro. 2018 Sep 12;54:41-57. doi: 10.1016/j.tiv.2018.09.006. [Epub ahead of print]

3.

Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic Studies.

Xia M, Huang R, Shi Q, Boyd WA, Zhao J, Sun N, Rice JR, Dunlap PE, Hackstadt AJ, Bridge MF, Smith MV, Dai S, Zheng W, Chu PH, Gerhold D, Witt KL, DeVito M, Freedman JH, Austin CP, Houck KA, Thomas RS, Paules RS, Tice RR, Simeonov A.

Environ Health Perspect. 2018 Jul 26;126(7):077010. doi: 10.1289/EHP2589. eCollection 2018 Jul.

4.

Confirmation of high-throughput screening data and novel mechanistic insights into VDR-xenobiotic interactions by orthogonal assays.

Mahapatra D, Franzosa JA, Roell K, Kuenemann MA, Houck KA, Reif DM, Fourches D, Kullman SW.

Sci Rep. 2018 Jun 11;8(1):8883. doi: 10.1038/s41598-018-27055-3.

5.

On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.

Judson RS, Houck KA, Watt ED, Thomas RS.

Regul Toxicol Pharmacol. 2017 Dec;91:39-49. doi: 10.1016/j.yrtph.2017.09.022. Epub 2017 Oct 6.

PMID:
28993267
6.

Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA) plates.

Strickland JD, Martin MT, Richard AM, Houck KA, Shafer TJ.

Arch Toxicol. 2018 Jan;92(1):487-500. doi: 10.1007/s00204-017-2035-5. Epub 2017 Aug 2.

PMID:
28766123
7.

Primary Cell Phenotypic Screening Illuminates ADRs and AOPs.

Bone AJ, Houck KA.

Cell Chem Biol. 2017 Jul 20;24(7):781-782. doi: 10.1016/j.chembiol.2017.07.001.

8.

An "EAR" on Environmental Surveillance and Monitoring: A Case Study on the Use of Exposure-Activity Ratios (EARs) to Prioritize Sites, Chemicals, and Bioactivities of Concern in Great Lakes Waters.

Blackwell BR, Ankley GT, Corsi SR, DeCicco LA, Houck KA, Judson RS, Li S, Martin MT, Murphy E, Schroeder AL, Smith ER, Swintek J, Villeneuve DL.

Environ Sci Technol. 2017 Aug 1;51(15):8713-8724. doi: 10.1021/acs.est.7b01613. Epub 2017 Jul 18.

9.

Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform.

Lynch C, Sakamuru S, Huang R, Stavreva DA, Varticovski L, Hager GL, Judson RS, Houck KA, Kleinstreuer NC, Casey W, Paules RS, Simeonov A, Xia M.

Toxicology. 2017 Jun 15;385:48-58. doi: 10.1016/j.tox.2017.05.001. Epub 2017 May 4.

10.

Comment on "On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens".

Houck KA, Judson RS, Knudsen TB, Martin MT, Richard AM, Crofton KM, Simeonov A, Paules RS, Bucher JR, Thomas RS.

Environ Health Perspect. 2017 Jan 1;125(1):A8-A11. doi: 10.1289/EHP881. No abstract available.

11.

ToxCast Chemical Landscape: Paving the Road to 21st Century Toxicology.

Richard AM, Judson RS, Houck KA, Grulke CM, Volarath P, Thillainadarajah I, Yang C, Rathman J, Martin MT, Wambaugh JF, Knudsen TB, Kancherla J, Mansouri K, Patlewicz G, Williams AJ, Little SB, Crofton KM, Thomas RS.

Chem Res Toxicol. 2016 Aug 15;29(8):1225-51. doi: 10.1021/acs.chemrestox.6b00135. Epub 2016 Jul 20.

12.

Evaluation of food-relevant chemicals in the ToxCast high-throughput screening program.

Karmaus AL, Filer DL, Martin MT, Houck KA.

Food Chem Toxicol. 2016 Jun;92:188-96. doi: 10.1016/j.fct.2016.04.012. Epub 2016 Apr 19.

13.

Environmental surveillance and monitoring--The next frontiers for high-throughput toxicology.

Schroeder AL, Ankley GT, Houck KA, Villeneuve DL.

Environ Toxicol Chem. 2016 Mar;35(3):513-25. doi: 10.1002/etc.3309.

PMID:
26923854
14.

Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.

Paul Friedman K, Watt ED, Hornung MW, Hedge JM, Judson RS, Crofton KM, Houck KA, Simmons SO.

Toxicol Sci. 2016 May;151(1):160-80. doi: 10.1093/toxsci/kfw034. Epub 2016 Feb 15.

15.

Using ToxCast™ Data to Reconstruct Dynamic Cell State Trajectories and Estimate Toxicological Points of Departure.

Shah I, Setzer RW, Jack J, Houck KA, Judson RS, Knudsen TB, Liu J, Martin MT, Reif DM, Richard AM, Thomas RS, Crofton KM, Dix DJ, Kavlock RJ.

Environ Health Perspect. 2016 Jul;124(7):910-9. doi: 10.1289/ehp.1409029. Epub 2015 Oct 16.

16.

Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.

Judson RS, Magpantay FM, Chickarmane V, Haskell C, Tania N, Taylor J, Xia M, Huang R, Rotroff DM, Filer DL, Houck KA, Martin MT, Sipes N, Richard AM, Mansouri K, Setzer RW, Knudsen TB, Crofton KM, Thomas RS.

Toxicol Sci. 2015 Nov;148(1):137-54. doi: 10.1093/toxsci/kfv168. Epub 2015 Aug 13.

17.

Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing.

Wetmore BA, Wambaugh JF, Allen B, Ferguson SS, Sochaski MA, Setzer RW, Houck KA, Strope CL, Cantwell K, Judson RS, LeCluyse E, Clewell HJ, Thomas RS, Andersen ME.

Toxicol Sci. 2015 Nov;148(1):121-36. doi: 10.1093/toxsci/kfv171. Epub 2015 Aug 6.

18.

An evaluation of 25 selected ToxCast chemicals in medium-throughput assays to detect genotoxicity.

Kligerman AD, Young RR, Stankowski LF Jr, Pant K, Lawlor T, Aardema MJ, Houck KA.

Environ Mol Mutagen. 2015 Jun;56(5):468-76. doi: 10.1002/em.21934. Epub 2014 Dec 23.

PMID:
25537651
19.

Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway.

Huang R, Sakamuru S, Martin MT, Reif DM, Judson RS, Houck KA, Casey W, Hsieh JH, Shockley KR, Ceger P, Fostel J, Witt KL, Tong W, Rotroff DM, Zhao T, Shinn P, Simeonov A, Dix DJ, Austin CP, Kavlock RJ, Tice RR, Xia M.

Sci Rep. 2014 Jul 11;4:5664. doi: 10.1038/srep05664.

20.

Multi-well microelectrode array recordings detect neuroactivity of ToxCast compounds.

Valdivia P, Martin M, LeFew WR, Ross J, Houck KA, Shafer TJ.

Neurotoxicology. 2014 Sep;44:204-17. doi: 10.1016/j.neuro.2014.06.012. Epub 2014 Jul 2.

PMID:
24997244
21.

Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses.

Rotroff DM, Martin MT, Dix DJ, Filer DL, Houck KA, Knudsen TB, Sipes NS, Reif DM, Xia M, Huang R, Judson RS.

Environ Sci Technol. 2014;48(15):8706-16. doi: 10.1021/es502676e. Epub 2014 Jul 10.

PMID:
24960280
22.

Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms.

Kleinstreuer NC, Yang J, Berg EL, Knudsen TB, Richard AM, Martin MT, Reif DM, Judson RS, Polokoff M, Dix DJ, Kavlock RJ, Houck KA.

Nat Biotechnol. 2014 Jun;32(6):583-91. doi: 10.1038/nbt.2914. Epub 2014 May 18.

PMID:
24837663
23.

Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate.

Wambaugh JF, Setzer RW, Pitruzzello AM, Liu J, Reif DM, Kleinstreuer NC, Wang NC, Sipes N, Martin M, Das K, DeWitt JC, Strynar M, Judson R, Houck KA, Lau C.

Toxicol Sci. 2013 Dec;136(2):308-27. doi: 10.1093/toxsci/kft204. Epub 2013 Sep 17.

PMID:
24046276
24.

Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells.

Rotroff DM, Dix DJ, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Reif DM, Richard AM, Sipes NS, Abassi YA, Jin C, Stampfl M, Judson RS.

Chem Res Toxicol. 2013 Jul 15;26(7):1097-107. doi: 10.1021/tx400117y. Epub 2013 Jun 10.

PMID:
23682706
25.

Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.

Wang A, Marinakos SM, Badireddy AR, Powers CM, Houck KA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Sep-Oct;5(5):430-48. doi: 10.1002/wnan.1229. Epub 2013 May 9.

PMID:
23661551
26.

Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays.

Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB.

Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16.

27.

Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.

Rotroff DM, Dix DJ, Houck KA, Knudsen TB, Martin MT, McLaurin KW, Reif DM, Crofton KM, Singh AV, Xia M, Huang R, Judson RS.

Environ Health Perspect. 2013 Jan;121(1):7-14. doi: 10.1289/ehp.1205065. Epub 2012 Sep 28.

28.

In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.

Kleinstreuer NC, Dix DJ, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Paul KB, Reif DM, Crofton KM, Hamilton K, Hunter R, Shah I, Judson RS.

Toxicol Sci. 2013 Jan;131(1):40-55. doi: 10.1093/toxsci/kfs285. Epub 2012 Sep 28.

PMID:
23024176
29.

Incorporating biological, chemical, and toxicological knowledge into predictive models of toxicity.

Dix DJ, Houck KA, Judson RS, Kleinstreuer NC, Knudsen TB, Martin MT, Reif DM, Richard AM, Shah I, Sipes NS, Kavlock RJ.

Toxicol Sci. 2012 Dec;130(2):440-1; author reply 442-3. doi: 10.1093/toxsci/kfs281. Epub 2012 Sep 14. No abstract available.

PMID:
22982683
30.

Zebrafish developmental screening of the ToxCast™ Phase I chemical library.

Padilla S, Corum D, Padnos B, Hunter DL, Beam A, Houck KA, Sipes N, Kleinstreuer N, Knudsen T, Dix DJ, Reif DM.

Reprod Toxicol. 2012 Apr;33(2):174-87. doi: 10.1016/j.reprotox.2011.10.018. Epub 2011 Dec 9.

PMID:
22182468
31.

Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.

Wetmore BA, Wambaugh JF, Ferguson SS, Sochaski MA, Rotroff DM, Freeman K, Clewell HJ 3rd, Dix DJ, Andersen ME, Houck KA, Allen B, Judson RS, Singh R, Kavlock RJ, Richard AM, Thomas RS.

Toxicol Sci. 2012 Jan;125(1):157-74. doi: 10.1093/toxsci/kfr254. Epub 2011 Sep 26.

PMID:
21948869
32.

Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential.

Gangwal S, Brown JS, Wang A, Houck KA, Dix DJ, Kavlock RJ, Hubal EA.

Environ Health Perspect. 2011 Nov;119(11):1539-46. doi: 10.1289/ehp.1103750. Epub 2011 Jul 25.

33.

Predictive model of rat reproductive toxicity from ToxCast high throughput screening.

Martin MT, Knudsen TB, Reif DM, Houck KA, Judson RS, Kavlock RJ, Dix DJ.

Biol Reprod. 2011 Aug;85(2):327-39. doi: 10.1095/biolreprod.111.090977. Epub 2011 May 12.

PMID:
21565999
34.

Chemical genomics profiling of environmental chemical modulation of human nuclear receptors.

Huang R, Xia M, Cho MH, Sakamuru S, Shinn P, Houck KA, Dix DJ, Judson RS, Witt KL, Kavlock RJ, Tice RR, Austin CP.

Environ Health Perspect. 2011 Aug;119(8):1142-8. doi: 10.1289/ehp.1002952. Epub 2011 May 4.

35.

Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment.

Judson RS, Kavlock RJ, Setzer RW, Hubal EA, Martin MT, Knudsen TB, Houck KA, Thomas RS, Wetmore BA, Dix DJ.

Chem Res Toxicol. 2011 Apr 18;24(4):451-62. doi: 10.1021/tx100428e. Epub 2011 Mar 8.

PMID:
21384849
36.

Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets.

Knudsen TB, Houck KA, Sipes NS, Singh AV, Judson RS, Martin MT, Weissman A, Kleinstreuer NC, Mortensen HM, Reif DM, Rabinowitz JR, Setzer RW, Richard AM, Dix DJ, Kavlock RJ.

Toxicology. 2011 Mar 28;282(1-2):1-15. doi: 10.1016/j.tox.2010.12.010. Epub 2011 Jan 18.

PMID:
21251949
37.

Endocrine profiling and prioritization of environmental chemicals using ToxCast data.

Reif DM, Martin MT, Tan SW, Houck KA, Judson RS, Richard AM, Knudsen TB, Dix DJ, Kavlock RJ.

Environ Health Perspect. 2010 Dec;118(12):1714-20. doi: 10.1289/ehp.1002180. Epub 2010 Sep 8.

38.

Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.

Rotroff DM, Wetmore BA, Dix DJ, Ferguson SS, Clewell HJ, Houck KA, Lecluyse EL, Andersen ME, Judson RS, Smith CM, Sochaski MA, Kavlock RJ, Boellmann F, Martin MT, Reif DM, Wambaugh JF, Thomas RS.

Toxicol Sci. 2010 Oct;117(2):348-58. doi: 10.1093/toxsci/kfq220. Epub 2010 Jul 16. Erratum in: Toxicol Sci. 2014 Feb;137(2):499. Dosage error in article text.

PMID:
20639261
39.

Analysis of eight oil spill dispersants using rapid, in vitro tests for endocrine and other biological activity.

Judson RS, Martin MT, Reif DM, Houck KA, Knudsen TB, Rotroff DM, Xia M, Sakamuru S, Huang R, Shinn P, Austin CP, Kavlock RJ, Dix DJ.

Environ Sci Technol. 2010 Aug 1;44(15):5979-85. doi: 10.1021/es102150z.

40.

Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals.

Rotroff DM, Beam AL, Dix DJ, Farmer A, Freeman KM, Houck KA, Judson RS, LeCluyse EL, Martin MT, Reif DM, Ferguson SS.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):329-46. doi: 10.1080/10937404.2010.483949.

PMID:
20574906
41.

In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project.

Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM, Reif DM, Rotroff DM, Shah I, Richard AM, Dix DJ.

Environ Health Perspect. 2010 Apr;118(4):485-92. doi: 10.1289/ehp.0901392.

42.

Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program.

Martin MT, Dix DJ, Judson RS, Kavlock RJ, Reif DM, Richard AM, Rotroff DM, Romanov S, Medvedev A, Poltoratskaya N, Gambarian M, Moeser M, Makarov SS, Houck KA.

Chem Res Toxicol. 2010 Mar 15;23(3):578-90. doi: 10.1021/tx900325g.

PMID:
20143881
43.

Profiling bioactivity of the ToxCast chemical library using BioMAP primary human cell systems.

Houck KA, Dix DJ, Judson RS, Kavlock RJ, Yang J, Berg EL.

J Biomol Screen. 2009 Oct;14(9):1054-66. doi: 10.1177/1087057109345525. Epub 2009 Sep 22.

PMID:
19773588
44.

Understanding mechanisms of toxicity: insights from drug discovery research.

Houck KA, Kavlock RJ.

Toxicol Appl Pharmacol. 2008 Mar 1;227(2):163-78. Epub 2007 Nov 4. Review.

PMID:
18063003
45.

Screening for activators of the wingless type/Frizzled pathway by automated fluorescent microscopy.

Borchert KM, Sells Galvin RJ, Hale LV, Trask OJ, Nickischer DR, Houck KA.

Methods Enzymol. 2006;414:140-50.

PMID:
17110191
46.

The ToxCast program for prioritizing toxicity testing of environmental chemicals.

Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ.

Toxicol Sci. 2007 Jan;95(1):5-12. Epub 2006 Sep 8.

PMID:
16963515
47.

A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity.

Schmidt RJ, Ficorilli JV, Zhang Y, Bramlett KS, Beyer TP, Borchert K, Dowless MS, Houck KA, Burris TP, Eacho PI, Liang G, Guo LW, Wilson WK, Michael LF, Cao G.

J Lipid Res. 2006 May;47(5):1037-44. Epub 2006 Jan 13.

48.

High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells.

Borchert KM, Galvin RJ, Frolik CA, Hale LV, Halladay DL, Gonyier RJ, Trask OJ, Nickischer DR, Houck KA.

Assay Drug Dev Technol. 2005 Apr;3(2):133-41.

PMID:
15871688
49.

Cyclic AMP-independent activation of CYP3A4 gene expression by forskolin.

Dowless MS, Barbee JL, Borchert KM, Bocchinfuso WP, Houck KA.

Eur J Pharmacol. 2005 Apr 4;512(1):9-13.

PMID:
15814084
50.

The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand.

Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett K, Stayrook KR.

Mol Pharmacol. 2005 Mar;67(3):948-54. Epub 2004 Dec 15.

Supplemental Content

Loading ...
Support Center